Axonics Retained Earnings (Accumulated Deficit) 2017-2024 | AXNX

Axonics retained earnings (accumulated deficit) from 2017 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Axonics Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-380
2022 $-374
2021 $-315
2020 $-234
2019 $-180
2018 $-100
2017 $-67
2016 $-49
Axonics Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $-393
2024-03-31 $-399
2023-12-31 $-380
2023-09-30 $-387
2023-06-30 $-391
2023-03-31 $-384
2022-12-31 $-374
2022-09-30 $-375
2022-06-30 $-359
2022-03-31 $-337
2021-12-31 $-315
2021-09-30 $-299
2021-06-30 $-282
2021-03-31 $-257
2020-12-31 $-234
2020-09-30 $-223
2020-06-30 $-214
2020-03-31 $-194
2019-12-31 $-180
2019-09-30 $-157
2019-06-30 $-132
2019-03-31 $-113
2018-12-31 $-100
2018-09-30 $-90
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2016-12-31 $-49
Sector Industry Market Cap Revenue
Medical Medical Information Systems $3.602B $0.366B
Axonics Modulation Technologies Inc. is focused on development and commercialization of a novel implantable SNM system for patients with urinary and bowel dysfunction and disrupting the SNM market. Axonics Modulation Technologies Inc. is based in Irvine, CA.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.978B 0.00
Inspire Medical Systems (INSP) United States $6.055B 188.82
Hims & Hers Health (HIMS) United States $5.988B 154.89
IRhythm Technologies (IRTC) United States $2.783B 0.00
Privia Health (PRVA) United States $2.736B 228.00
Enovis (ENOV) United States $2.646B 17.94
Omnicell (OMCL) United States $2.263B 74.03
Azenta (AZTA) United States $2.242B 127.33
10x Genomics (TXG) United States $1.925B 0.00
Clover Health Investments (CLOV) United States $1.657B 0.00
Schrodinger (SDGR) United States $1.422B 0.00
Phreesia (PHR) United States $1.252B 0.00
Standard BioTools (LAB) United States $0.830B 0.00
Fulgent Genetics (FLGT) United States $0.613B 0.00
Talkspace (TALK) United States $0.586B 0.00
Butterfly Network (BFLY) United States $0.582B 0.00
Definitive Healthcare (DH) United States $0.508B 88.00
Health Catalyst (HCAT) United States $0.506B 0.00
Pulmonx (LUNG) United States $0.298B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.248B 0.00
TruBridge (TBRG) United States $0.214B 62.22
P3 Health Partners (PIII) United States $0.142B 0.00
American Well (AMWL) United States $0.139B 0.00
EUDA Health Holdings (EUDA) Singapore $0.106B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
HeartBeam (BEAT) United States $0.064B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.050B 0.00
Outset Medical (OM) United States $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
CareCloud (CCLD) United States $0.042B 0.00
Movano (MOVE) United States $0.028B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00